Perlmutter Cancer Center at NYU Langone Hospital- Long Island — Mineola, New York

Perlmutter Cancer Center at NYU Langone Hospital- Long Island is a clinical research site located in Mineola, New York, United States 11501.

Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Perlmutter Cancer Center at NYU Langone Hospital- Long Island has participated in 33 clinical trials with 24 currently active.

Therapeutic areas: Breast Cancer, Melanoma, Solid Cancer.

Sponsors: Pfizer, Merck Sharp & Dohme LLC, Daiichi Sankyo.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Mineola

Browse all research sites in New York · View every site in Mineola

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Perlmutter Cancer Center at NYU Langone Hospital- Long Island?

Perlmutter Cancer Center at NYU Langone Hospital- Long Island has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Perlmutter Cancer Center at NYU Langone Hospital- Long Island conducted?

Perlmutter Cancer Center at NYU Langone Hospital- Long Island has 33 clinical trials on record, with 24 currently active. Their work covers Breast Cancer, Melanoma, Solid Cancer.

Is Perlmutter Cancer Center at NYU Langone Hospital- Long Island accredited by Crixeo Clinical Trials?

Perlmutter Cancer Center at NYU Langone Hospital- Long Island has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Perlmutter Cancer Center at NYU Langone Hospital- Long Island?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.